Compositions – Nonreactive analytical – testing – or indicating compositions
Patent
1981-08-12
1982-11-09
Gron, Teddy S.
Compositions
Nonreactive analytical, testing, or indicating compositions
23230B, 424 2, 424 3, 424101, 435 4, G01N 3348, C09K 300
Patent
active
043583946
ABSTRACT:
A process for preparing whole blood reference controls having long term stability up to six months for devices using electronic means for whole blood determinations including platelet count and mean cell volume and red blood distribution width. The preconditioning diluent for the red blood cells consists essentially of an aqueous solution of lactose, sodium azide, and a non-ionic surfactant and is pH buffered and osmolality adjusted. The media of the whole blood control includes lactose, fungicides and antibiotics, and supplementary agents including purine nucleosides. It also includes additional components which alter red blood cell membranes including bile salts and cholic acid derivatives, phenothiazine compounds and the salts thereof having antihistamine properties, and 4-aminobenzoic acid ester derivatives and their salts having local anesthetic properties. In the process, the red blood cells are separated from the whole blood and preconditioned by the diluent to attain desired size distribution width and volume. The preconditioned red blood cells then are mixed in the media in suitable number for yielding the desired cell count for the whole blood reference control.
REFERENCES:
patent: 3574137 (1971-04-01), Decasperis
patent: 3873467 (1975-03-01), Hunt
patent: 3956477 (1976-05-01), Price et al.
patent: 3962125 (1976-06-01), Armstrong
patent: 3973913 (1976-08-01), Louderback et al.
patent: 3977995 (1976-08-01), Louderback et al.
patent: 4102810 (1978-07-01), Armstrong
patent: 4179398 (1979-12-01), Hunt
patent: 4213876 (1980-07-01), Crews et al.
patent: 4264470 (1981-04-01), Chastain, Jr. et al.
patent: 4289756 (1981-09-01), Zimmermann et al.
Billington, D., et al, Biochim. Biophys. Acta., vol. 509, pp. 33-47 (1978).
Coleman, R., et al., Biochim. Biophys. Acta., vol. 426, pp. 776-780 (1976).
Seeman, P., et al; Biochem. Pharmacology, vol. 15, pp. 1737-1752, pp. 1753-1766 (1966).
Premachamdrm, B. R., et al; Biochem. Biophys. Acta., vol. 550, pp. 245-258 (1979).
Ohki, S., et al; Biochim. Biphys. Acta., vol. 507, pp. 395-407 (1978).
Fisher, H., et al., Proc. 10th Congr. Int. Soc. Blood Transf., Stockholm 1964, pp. 616-626 (1965).
Akerblom, O., et al; Transfusion, vol. 7, No. 1, pp. 1-9, (Jan.-Feb. 1967).
Dern, R. J., et al; J. Lab. Clin. Med., vol. 69, No. 6, pp. 968-978 (Jun. 1967).
Nakao, M., et al; Nature, vol. 187, pp. 945-946 (Sep. 1960), vol. 197, pp. 877-878 (Jun. 2, 1962).
Chastain, Jr. David L.
Crews Harold R.
Ledis Stephen L.
Coulter Electronics Inc.
Gron Teddy S.
Hibnick Gerald R.
Sparks Meredith
LandOfFree
Process for preparing whole blood reference controls having long does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for preparing whole blood reference controls having long, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for preparing whole blood reference controls having long will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-745236